These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2462601)

  • 41. Isolated detection of cryptococcal polysaccharide antigen in patients with cryptococcosis.
    Chakrabarti A; Gupta V
    Clin Infect Dis; 1997 Dec; 25(6):1494-5. PubMed ID: 9431417
    [No Abstract]   [Full Text] [Related]  

  • 42. Heat killed cells of Cryptococcus neoformans var. grubii induces protective immunity in rats: immunological and histopathological parameters.
    Baronetti JL; Chiapello LS; Aoki MP; Gea S; Masih DT
    Med Mycol; 2006 Sep; 44(6):493-504. PubMed ID: 16966166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cryptococcal immunity and immunostimulation.
    Murphy JW
    Adv Exp Med Biol; 1992; 319():225-30. PubMed ID: 1414597
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical and serologic evaluation of cats with cryptococcosis.
    Flatland B; Greene RT; Lappin MR
    J Am Vet Med Assoc; 1996 Sep; 209(6):1110-3. PubMed ID: 8800258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoadsorption of Cryptococcus-specific suppressor T-cell factors.
    Mosley RL; Murphy JW; Cox RA
    Infect Immun; 1986 Mar; 51(3):844-50. PubMed ID: 2936685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans.
    Fromtling RA; Blackstock R; Hall NK; Bulmer GS
    Mycopathologia; 1979 Sep; 68(3):179-81. PubMed ID: 394001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T lymphocyte and monocyte interaction by CD40/CD40 ligand facilitates a lymphoproliferative response and killing of Cryptococcus neoformans in vitro.
    Vecchiarelli A; Retini C; Pietrella D; Monari C; Kozel TR
    Eur J Immunol; 2000 May; 30(5):1385-93. PubMed ID: 10820385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A case of multiple cavities on chest film with high titer of serum cryptococcal antigen].
    Maeda J; Tamura S; Hada T; Higashino K; Yoshimoto T; Hirao F
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Nov; 27(11):1330-4. PubMed ID: 2696803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cellular immunity in a cutaneous model of cryptococcosis.
    Domer JE; Lyon FL; Murphy JW
    Infect Immun; 1983 Jun; 40(3):1052-9. PubMed ID: 6343238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody-mediated effects against Cryptococcus neoformans: evidence for interdependency and collaboration between humoral and cellular immunity.
    Vecchiarelli A; Casadevall A
    Res Immunol; 1998; 149(4-5):321-33; discussion 500-3. PubMed ID: 9720950
    [No Abstract]   [Full Text] [Related]  

  • 51. In vitro effect of cyclosporine on interleukin-2 receptor expression stimulated by Cryptococcus neoformans.
    Miller GP; Lewis DE
    J Infect Dis; 1987 Apr; 155(4):799-802. PubMed ID: 3102632
    [No Abstract]   [Full Text] [Related]  

  • 52. Detection of IgM and IgG antibodies to Cryptococcus neoformans proteins in blood donors and HIV patients with active cryptococcosis.
    Chai HC; Tay ST
    Mycoses; 2009 Mar; 52(2):166-70. PubMed ID: 18643920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of agglutinating antibody in experimental cryptococcal meningitis.
    Perfect JR; Lang SD; Durack DT
    Br J Exp Pathol; 1981 Dec; 62(6):595-9. PubMed ID: 7034765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T Cell-Restricted Notch Signaling Contributes to Pulmonary Th1 and Th2 Immunity during
    Neal LM; Qiu Y; Chung J; Xing E; Cho W; Malachowski AN; Sandy-Sloat AR; Osterholzer JJ; Maillard I; Olszewski MA
    J Immunol; 2017 Jul; 199(2):643-655. PubMed ID: 28615417
    [No Abstract]   [Full Text] [Related]  

  • 55. Experimental cryptococcosis in normal and B-cell-deficient mice.
    Monga DP; Kumar R; Mohapatra LN; Malaviya AN
    Infect Immun; 1979 Oct; 26(1):1-3. PubMed ID: 387600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of cell-mediated immunity in cryptococcosis. II. Characterization of first-order T suppressor cells (Ts1) and induction of second-order suppressor cells.
    Murphy JW; Mosley RL; Moorhead JW
    J Immunol; 1983 Jun; 130(6):2876-81. PubMed ID: 6222119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coagglutination (COA) test for the rapid diagnosis of cryptococcal meningitis.
    Koshi G; Anandi V; Shastry JC; Cheriyan AM; Abraham J
    J Med Microbiol; 1989 Jul; 29(3):189-94. PubMed ID: 2664182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro interactions of immune lymphocytes and Cryptococcus neoformans.
    Fung PY; Murphy JW
    Infect Immun; 1982 Jun; 36(3):1128-38. PubMed ID: 7047393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of capsule and interleukin-6 in long-term immune control of Cryptococcus neoformans infection by specifically activated human peripheral blood mononuclear cells.
    Siddiqui AA; Shattock RJ; Harrison TS
    Infect Immun; 2006 Sep; 74(9):5302-10. PubMed ID: 16926424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preventing deaths from cryptococcal meningitis: from bench to bedside.
    Roy M; Chiller T
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.